← Medical directorySide effect
Self-harm
A population-based study in Ontario of men aged 66 and over treated with finasteride for benign prostatic hyperplasia found a higher risk of self-harm during the first 18 months of treatment (HR 1.88), but not thereafter.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.





